PA
Perceptive Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153M | Sell |
2,418,299
-130,146
| -5% | -$8.22M | 5.67% | 4 |
|
|
2025
Q1 | $135M | Sell |
2,548,445
-1,132,028
| -31% | -$60M | 4.77% | 5 |
|
|
2024
Q4 | $206M | Buy |
3,680,473
+120,259
| +3% | +$6.73M | 5.68% | 4 |
|
|
2024
Q3 | $187M | Buy |
3,560,214
+113,635
| +3% | +$5.95M | 3.95% | 6 |
|
|
2024
Q2 | $142M | Buy |
3,446,579
+178,000
| +5% | +$7.31M | 3.41% | 6 |
|
|
2024
Q1 | $142M | Buy |
3,268,579
+1,114,469
| +52% | +$48.3M | 2.48% | 8 |
|
|
2023
Q4 | $99M | Buy |
2,154,110
+1,773,282
| +466% | +$81.5M | 2.21% | 8 |
|
|
2023
Q3 | $8.73M | Buy |
+380,828
| New | +$8.73M | 0.29% | 62 |
|
|
2020
Q2 | – | Sell |
-170,859
| Closed | -$2.6M | – | 134 |
|
|
2020
Q1 | $2.6M | Hold |
170,859
| – | – | 0.07% | 89 |
|
|
2019
Q4 | $3.92M | Buy |
+170,859
| New | +$3.92M | 0.08% | 83 |
|
|
2019
Q3 | – | Sell |
-262,970
| Closed | -$5.79M | – | 115 |
|
|
2019
Q2 | $5.79M | Sell |
262,970
-240,000
| -48% | -$5.28M | 0.13% | 78 |
|
|
2019
Q1 | $13.8M | Sell |
502,970
-6,216
| -1% | -$170K | 0.39% | 51 |
|
|
2018
Q4 | $13.8M | Sell |
509,186
-155,000
| -23% | -$4.19M | 0.52% | 43 |
|
|
2018
Q3 | $19.4M | Sell |
664,186
-136,500
| -17% | -$3.98M | 0.52% | 43 |
|
|
2018
Q2 | $25M | Buy |
800,686
+208,400
| +35% | +$6.51M | 0.66% | 41 |
|
|
2018
Q1 | $11.8M | Sell |
592,286
-152,849
| -21% | -$3.04M | 0.33% | 57 |
|
|
2017
Q4 | $21.7M | Buy |
+745,135
| New | +$21.7M | 0.72% | 36 |
|